Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL) [clinicaltrials:NCT00131053]
Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL) [clinicaltrials:NCT00131053]
Bio2RDF identifier
NCT00131053
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00131053
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
arm group [clinicaltrials_vocabulary:arm-group]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpose of this stu ...... with the pediatric protocol.
brief title [clinicaltrials_vocabulary:brief-title]
Applying Pediatric Regimens to ...... e Lymphoblastic Leukemia (ALL)
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
completion date [clinicaltrials_vocabulary:completion-date]
2011-09-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
The prognosis for adult ...... ed maintenance
therapy.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2005-08-15T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Acute lymphoblastic leukemia
BCR-ABL-negative
acute lymphoblastic leukemia
newly diagnosed
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2008-11-13T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00131053
number of arms [clinicaltrials_vocabulary:number-of-arms]
official title [clinicaltrials_vocabulary:official-title]
Phase 2 Study of Applying Pedi ...... e Acute Lymphoblastic Leukemia
org study id [clinicaltrials_vocabulary:org-study-id]
JALSG ALL202-U
overall contact [clinicaltrials_vocabulary:overall-contact]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2011-05-01T00:00:00Z
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2002-09-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2008-11-01T00:00:00Z
identifier
clinicaltrials:NCT00131053
title
Applying Pediatric Regimens to ...... e Lymphoblastic Leukemia (ALL)
@en
type
label
Applying Pediatric Regimens to ...... ) [clinicaltrials:NCT00131053]
@en